caffeine has been researched along with losartan potassium in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Perry, PJ; Smith, DA | 1 |
| Catlin, DH; Hatton, CK | 1 |
| Ghaphery, NA | 1 |
| Landry, GL; Thein, JM; Thein, LA | 1 |
| Fang, S; Gamsu, HR; Greenough, A; Marsden, JT; Peters, TJ; Sherwood, RA | 1 |
| Juhn, MS | 1 |
| HANSEN, P | 1 |
| Feller, SM; Fichelson, S; Schmidt, EK | 1 |
| Gupta, V; Lipsitz, LA | 1 |
| Grossman, E; Messerli, FH | 1 |
| Ayoko, GA; Hughes, J; Izake, EL; Lott, WB; Sillence, M | 1 |
| Arias-Reyes, C; Bairam, A; Gonzales, M; Iturri, P; Joseph, V; Laouafa, S; Marcouiller, F; Soliz, J | 1 |
| Siahanidou, T; Spiliopoulou, C | 1 |
8 review(s) available for caffeine and losartan potassium
| Article | Year |
|---|---|
The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents.
Topics: Amphetamines; Caffeine; Cocaine; Doping in Sports; Erythropoietin; Growth Hormone; Humans; Male; Metabolism; Substance-Related Disorders; Time Factors | 1992 |
Use and abuse of anabolic and other drugs for athletic enhancement.
Topics: Adrenergic beta-Antagonists; Amphetamines; Anabolic Agents; Caffeine; Diuretics; Doping in Sports; Ephedrine; Erythropoietin; Growth Hormone; Humans; Recombinant Proteins; Substance Abuse Detection | 1991 |
Performance-enhancing drugs.
Topics: Adolescent; Adult; Amphetamines; Anabolic Agents; Blood Transfusion, Autologous; Caffeine; Doping in Sports; Erythropoietin; Female; Humans; Male; Sodium Bicarbonate | 1995 |
Ergogenic aids.
Topics: Anabolic Agents; Animals; Caffeine; Clenbuterol; Doping in Sports; Erythropoietin; Exercise; Growth Hormone; Hemodynamics; Humans; Muscle, Skeletal; Substance Abuse Detection | 1995 |
Ergogenic aids in aerobic activity.
Topics: Antioxidants; Caffeine; Central Nervous System Stimulants; Dietary Carbohydrates; Dietary Supplements; Energy Metabolism; Erythropoietin; Exercise; Humans; Physical Endurance; Pyruvic Acid | 2002 |
Orthostatic hypotension in the elderly: diagnosis and treatment.
Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Aging; Anti-Inflammatory Agents; Blood Pressure Determination; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Erythropoietin; Fludrocortisone; Geriatrics; Humans; Hypotension, Orthostatic; Midodrine; Posture; Prevalence; Prostaglandin Antagonists; Risk Reduction Behavior; United States | 2007 |
Drug-induced hypertension: an unappreciated cause of secondary hypertension.
Topics: Adrenal Cortex Hormones; Alcohol Drinking; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Caffeine; Cocaine; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Glycyrrhiza; Gonadal Steroid Hormones; Humans; Hypertension; Immunosuppressive Agents; Vascular Endothelial Growth Factor A | 2012 |
Pharmacological Neuroprotection of the Preterm Brain: Current Evidence and Perspectives.
Topics: Brain; Caffeine; Erythropoietin; Female; Humans; Infant, Newborn; Infant, Premature; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth | 2022 |
1 trial(s) available for caffeine and losartan potassium
| Article | Year |
|---|---|
Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants.
Topics: Anemia; Apnea; Caffeine; Erythropoietin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Theophylline | 1998 |
5 other study(ies) available for caffeine and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
THE PRECIPITATION OF ERYTHROPOIETIN FROM URINE BY MEANS OF TANNIC ACID. USE IN ANALYSIS AND PRODUCTION OF ERYTHROPOIETIN-RICH PREPARATION.
Topics: Acetates; Alcohols; Ammonia; Caffeine; Epoetin Alfa; Erythropoietin; Ethanol; Humans; Hydrogen-Ion Concentration; Immunoelectrophoresis; Tannins; Urine | 1963 |
PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.
Topics: Butadienes; Caffeine; Cells, Cultured; Chromones; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Erythroid Precursor Cells; Erythropoietin; Extracellular Signal-Regulated MAP Kinases; Fetal Blood; Humans; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; ras Proteins | 2004 |
Ultra sensitive label free surface enhanced Raman spectroscopy method for the detection of biomolecules.
Topics: Animals; Antibodies, Monoclonal; Biosensing Techniques; Caffeine; Erythropoietin; Gold; Humans; Metal Nanoparticles; Mice; Silicon Dioxide; Spectrum Analysis, Raman; Surface Properties | 2014 |
Erythropoietin and caffeine exert similar protective impact against neonatal intermittent hypoxia: Apnea of prematurity and sex dimorphism.
Topics: Animals; Animals, Newborn; Brain Stem; Caffeine; Erythropoietin; Female; Hypoxia, Brain; Male; Neuroprotective Agents; Oxidative Stress; Rats; Respiration; Sex Characteristics | 2019 |